23 May 2013
Keywords: Forest, Almirall, Aclidinium, COPD, USA, FDA, General manager Germany
Article | 04 July 2011
Spain’s largest pharma company Almirall (ALM. MC) and US marketing partner Forest Laboratories (NYSE: FRX) revealed on Friday ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 July 2011
22 May 2013
© 2013 thepharmaletter.com